Moving and handling specialists Care & Independence have been acquired by GBUK Group, a portfolio company of A&M Capital Europe, a London-based private equity firm with €650 million of commitments under management.
The Care & Independence Executive Management Team, Ian Jones (Managing Director) and James Bennett (Sales & Marketing Director), are remaining within the business. James Bennett declared that Care & Independence “will continue to passionately drive the business forwards towards to the goal of improving 1 million lives per year by 2031, now strengthened in support by the broader, highly expert teams at GBUK. The acquisition will bolster capability to invest in R&D, delivering innovative, best-in-class products and supporting services within Care & Independence whilst broadening product portfolios, market reach and penetration to offer even greater value to our customers and end users.”
The Yorkshire-based GBUK designs, develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. It is a top 20 supplier to the UK NHS and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. Like Care & Independence, GBUK operates a clinician-orientated high-touch sales model that supports occupational therapists with clinical product training and patient requirement assessments.
A spokesperson for GBUK said “This strategic acquisition marks a significant milestone in our mission to enhance healthcare solutions and expand our product offering. By aligning Care & Independence’s expertise and product lines within the GBUK Group strategy, we are poised to deliver even greater value to our customers and communities. This acquisition will not only broaden our market reach but also strengthen our commitment to improving lives through cutting-edge healthcare solutions. We extend a warm welcome to the Care & Independence team and look forward to a prosperous journey ahead as we join forces to achieve new heights of success together.”
-----------------------------------------------
About GBUK
Headquartered in the United Kingdom, GBUK designs, develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK NHS and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinging on wrap-around services.
About A&M Capital Europe
AMCE is a London-headquartered private equity investment firm specialising in building pan-European platform companies through buy-and-build and organic growth initiatives. AMCE Fund I currently has €650 million of commitments under management, and C&I represents AMCE’s twenty-second transaction. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm that manages funds and accounts with commitments totalling ~€5.5 billion across four investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest growth and operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.